You have read all your free articles, to continue reading subscribe to read the rest of this content.
Following receipt of all regulatory approvals, Agnafit Bidco extends the acceptance period for the public offer to the shareholders of Sobi and announces its intention not to increase the price of SEK 235 per share in the Offer. On 2 September 2021, Advent International Corporation1 and Aurora InAlready a subscriber…
The sale of the rights to Karolinska Institutet Innovations AB project Extroducer to the company Smart Wise AB is KI Innovations second major deal in fewer than six months. The device is a microcatheter with unique features that make it possible to deliver drugs directly to hard- to-reach organs. Already a subscriber…
AstraZeneca has entered into a definitive agreement to acquire ZS Pharma, a biopharmaceutical company based in San Mateo, California. ZS Pharma uses its proprietary ion-trap technology to develop novel treatments for hyperkalaemia (high potassium levels), a serious condition of elevated potassiAlready a subscriber Login You have read all your free…
AstraZeneca has agreed to sell the global commercial rights to Inderal, Tenormin, Tenoretic, Zestril and Zestoretic to Atnahs Pharma. The agreement excludes the rights in the US and India, which were previously divested, and in Japan, which will be retained by AstraZeneca. The medicines, used Already a subscriber Login You…
